Pharmaceutical Patent Law, 2nd Edition, 2012 Cumulative Supplement

The all-new 2012 Cumulative Supplement advises practitioners of recent significant events, including: Extensive changes brought about by the Leahy-Smith America Invents Act The Supreme Court's decisions in Mayo v. Prometheus and Caraco v. Novo Nordisk The FDA's new law of biosimilars A section amplifying international and comparative data protection law Discussion of the experimental use privilege and post-approval activities Analysis of the multiple 30-month stays under the MMA